SANTOSH MAHARJAN: Open Payments
NPI 1073751616 · WARSAW, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$312 in 14 payments from 6 companies in 2025. Trend: 2023 $642 · 2024 $372 · 2025 $312
Food & beverage: $312
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $143 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
| Alkermes, Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: ABILIFY ASIMTUFII, COBENFY, ARISTADA, ABILIFY MAINTENA, REXULTI, CAPLYTA, Auvelity, TRINTELLIX.
Industry payments across IN — which companies pay providers there.
